Literature DB >> 11287353

Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis.

P Iozzo1, T Pratipanawatr, H Pijl, C Vogt, V Kumar, R Pipek, M Matsuda, L J Mandarino, K J Cusi, R A DeFronzo.   

Abstract

Although chronic hyperinsulinemia has been shown to induce insulin resistance, the basic cellular mechanisms responsible for this phenomenon are unknown. The present study was performed 1) to determine the time-related effect of physiological hyperinsulinemia on glycogen synthase (GS) activity, hexokinase II (HKII) activity and mRNA content, and GLUT-4 protein in muscle from healthy subjects, and 2) to relate hyperinsulinemia-induced alterations in these parameters to changes in glucose metabolism in vivo. Twenty healthy subjects had a 240-min euglycemic insulin clamp study with muscle biopsies and then received a low-dose insulin infusion for 24 (n = 6) or 72 h (n = 14) (plasma insulin concentration = 121 +/- 9 or 143 +/- 25 pmol/l, respectively). During the baseline insulin clamp, GS fractional velocity (0.075 +/- 0.008 to 0.229 +/- 0.02, P < 0.01), HKII mRNA content (0.179 +/- 0.034 to 0.354 +/- 0.087, P < 0.05), and HKII activity (2.41 +/- 0.63 to 3.35 +/- 0.54 pmol x min(-1) x ng(-1), P < 0.05), as well as whole body glucose disposal and nonoxidative glucose disposal, increased. During the insulin clamp performed after 24 and 72 h of sustained physiological hyperinsulinemia, the ability of insulin to increase muscle GS fractional velocity, total body glucose disposal, and nonoxidative glucose disposal was impaired (all P < 0.01), whereas the effect of insulin on muscle HKII mRNA, HKII activity, GLUT-4 protein content, and whole body rates of glucose oxidation and glycolysis remained unchanged. Muscle glycogen concentration did not change [116 +/- 28 vs. 126 +/- 29 micromol/kg muscle, P = nonsignificant (NS)] and was not correlated with the change in nonoxidative glucose disposal (r = 0.074, P = NS). In summary, modest chronic hyperinsulinemia may contribute directly (independent of change in muscle glycogen concentration) to the development of insulin resistance by its impact on the GS pathway.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287353     DOI: 10.1152/ajpendo.2001.280.5.E712

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  15 in total

1.  Intravenous estrogens increase insulin clearance and action in postmenopausal women.

Authors:  R E Van Pelt; W S Gozansky; R S Schwartz; W M Kohrt
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-04-08       Impact factor: 4.310

Review 2.  Minireview: Dopaminergic regulation of insulin secretion from the pancreatic islet.

Authors:  Alessandro Ustione; David W Piston; Paul E Harris
Journal:  Mol Endocrinol       Date:  2013-06-06

3.  Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1.

Authors:  Rachel Zhande; John J Mitchell; Jiong Wu; Xiao Jian Sun
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  The influence of calcium supplementation on substrate metabolism during exercise in humans: a randomized controlled trial.

Authors:  J T Gonzalez; B P Green; M D Campbell; P L S Rumbold; E J Stevenson
Journal:  Eur J Clin Nutr       Date:  2014-03-19       Impact factor: 4.016

5.  Effects of hyperinsulinemia on lipolytic function of three-dimensional adipocyte/endothelial co-cultures.

Authors:  Jennifer H Choi; Jeffrey M Gimble; Gordana Vunjak-Novakovic; David L Kaplan
Journal:  Tissue Eng Part C Methods       Date:  2010-10       Impact factor: 3.056

Review 6.  Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents.

Authors:  Antonino Di Pino; Ralph A DeFronzo
Journal:  Endocr Rev       Date:  2019-12-01       Impact factor: 19.871

7.  Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass.

Authors:  Lydia-Ann Harris; Brandon D Kayser; Consuelo Cefalo; Luca Marini; Jeramie D Watrous; Jeffrey Ding; Mohit Jain; Jeffrey G McDonald; Bonne M Thompson; Elisa Fabbrini; J Christopher Eagon; Bruce W Patterson; Bettina Mittendorfer; Geltrude Mingrone; Samuel Klein
Journal:  Cell Metab       Date:  2019-10-03       Impact factor: 27.287

8.  Obesity Is Associated With Increased Basal and Postprandial β-Cell Insulin Secretion Even in the Absence of Insulin Resistance.

Authors:  Stephan van Vliet; Han-Chow E Koh; Bruce W Patterson; Mihoko Yoshino; Richard LaForest; Robert J Gropler; Samuel Klein; Bettina Mittendorfer
Journal:  Diabetes       Date:  2020-07-10       Impact factor: 9.461

Review 9.  Gastrointestinal dopamine as an anti-incretin and its possible role in bypass surgery as therapy for type 2 diabetes with associated obesity.

Authors:  Suleman Chaudhry; Marilia Bernardes; Paul E Harris; Antonella Maffei
Journal:  Minerva Endocrinol       Date:  2015-10-27       Impact factor: 2.184

Review 10.  Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.

Authors:  Ralph A DeFronzo; Devjit Tripathy
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.